Ki67 Predicts Progression in Early CIN: Validation of a Multivariate Progression-Risk Model

This study of early CIN biopsies (25 CIN1 and 65 CIN2) with long follow-up was done to validate, in a new group of patients, the value of Ki67 immuno-quantitative features to predict high CIN grade in a follow-up biopsy (often denoted to as “progression”), as described in a previous study. Each biop...

Full description

Saved in:
Bibliographic Details
Main Authors: Arnold-Jan Kruse, Jan P. A. Baak, Emiel A. Janssen, Kjell-Henning Kjellevold, Bent Fianec, Kjell Lovslett, Johan Bergh, Stanley Robboy
Format: Article
Language:English
Published: Wiley 2004-01-01
Series:Cellular Oncology
Online Access:http://dx.doi.org/10.1155/2004/108305
Tags: Add Tag
No Tags, Be the first to tag this record!